Apolipoprotein A-I and A-I mimetic peptides: a role in atherosclerosis

References

• PackardRRLichtmanAHLibbyPInnate and adaptive immunity in atherosclerosisSemin Immunopathol20093152219449008
   PubMed Web of Science ®Google Scholar
• HanssonGKHermanssonAThe immune system in atherosclerosisNat Immunol20111220421221321594
   PubMed Web of Science ®Google Scholar
• GetzGSVanderlaanPAReardonCAThe immune system and murine atherosclerosisCurr Drug Targets200781297130618220706
   PubMed Web of Science ®Google Scholar
• McGillHCJrMcMahanCADeterminants of atherosclerosis in the young. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research GroupAm J Cardiol19988230T36T
   PubMed Web of Science ®Google Scholar
• McGillHCJrMcMahanCAGiddingSSPreventing heart disease in the 21st century: implications of the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) studyCirculation20081171216122718316498
   PubMed Web of Science ®Google Scholar
• ChiuJJChienSEffects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectivesPhysiol Rev20119132738721248169
   PubMed Web of Science ®Google Scholar
• VanderLaanPAReardonCAGetzGSSite specificity of atherosclerosis: site-selective responses to atherosclerotic modulatorsArterioscler Thromb Vasc Biol200424122214604830
   PubMed Web of Science ®Google Scholar
• GoldsteinJLBrownMSThe low-density lipoprotein pathway and its relationship to atherosclerosisAnn Rev Biochem197746897930197883
   PubMed Web of Science ®Google Scholar
• GoldsteinJLHoYKBasuSKBrownMSBinding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol depositionProc Natl Acad Sci U S A197976333337218198
   PubMed Web of Science ®Google Scholar
• CohenJCBoerwinkleEMosleyTHJrHobbsHHSequence variations in PCSK9, low LDL, and protection against coronary heart diseaseN Engl J Med20063541264127216554528
   PubMed Web of Science ®Google Scholar
• HortonJDCohenJCHobbsHHPCSK9: a convertase that coordinates LDL catabolismJ Lipid Res200950SupplS17217719020338
   PubMed Web of Science ®Google Scholar
• GetzGSReardonCADiet and murine atherosclerosisArterioscler Thromb Vasc Biol20062624224916373607
   PubMed Web of Science ®Google Scholar
• NavabMAnantharamaiahGMReddySTThe oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDLJ Lipid Res200445993100715060092
   PubMed Web of Science ®Google Scholar
• MillerYIChoiSHFangLTsimikasSLipoprotein modification and macrophage uptake: role of pathologic cholesterol transport in atherogenesisSubcell Biochem20105122925120213546
   PubMedGoogle Scholar
• BeckerLGharibSAIrwinADA macrophage sterol-responsive network linked to atherogenesisCell Metab20101112513520142100
   PubMed Web of Science ®Google Scholar
• GalkinaELeyKLeukocyte influx in atherosclerosisCurr Drug Targets200781239124818220701
   PubMed Web of Science ®Google Scholar
• ChouMYHartvigsenKHansenLFOxidation-specific epitopes are important targets of innate immunityJ Intern Med200826347948818410591
   PubMed Web of Science ®Google Scholar
• KlingenbergRLebensMHermanssonAIntranasal immunization with an apolipoprotein B-100 fusion protein induces antigen-specific regulatory T cells and reduces atherosclerosisArterioscler Thromb Vasc Biol20103094695220167655
   PubMed Web of Science ®Google Scholar
• FredriksonGNBjörkbackaHSöderbergILjungcrantzINilssonJTreatment with apoB peptide vaccines inhibits atherosclerosis in human apo B-100 transgenic mice without inducing an increase in peptide-specific antibodiesJ Intern Med200826456357018783480
   PubMed Web of Science ®Google Scholar
• FengBYaoPMLiYThe endoplasmic reticulum is the site of cholesterol-induced cytotoxicity in macrophagesNat Cell Biol2003578179212907943
   PubMed Web of Science ®Google Scholar
• TabasIMacrophage death and defective inflammation resolution in atherosclerosisNat Rev Immunol201010364619960040
   PubMed Web of Science ®Google Scholar
• LlodráJAngeliVLiuJEmigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaquesProc Natl Acad Sci U S A2004101117791178415280540
   PubMed Web of Science ®Google Scholar
• GordonDJProbstfieldJLGarrisonRJHigh-density lipoprotein cholesterol and cardiovascular diseaseCirculation1989798152642759
   PubMed Web of Science ®Google Scholar
• PlumpASScottCJBreslowJLHuman apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in apolipoprotein E-deficient miceProc Natl Acad Sci U S A199491960796117937814
   PubMed Web of Science ®Google Scholar
• RongJXLiJReisEDElevating high-density lipoprotein cholesterol in apolipoprotein E-deficient mice remodels advanced atherosclerotic lesions by decreasing macrophage and increasing smooth muscle cell contentCirculation20011042447245211705823
   PubMed Web of Science ®Google Scholar
• TangiralaRKTsukamotoKChunSHUsherDPuréERaderDJRegression of atherosclerosis induced by liver-directed gene transfer of apolipoprotein A-I in miceCirculation19991001816182210534470
   PubMed Web of Science ®Google Scholar
• VaisarTPennathurSGreenPSShotgun proteomics implicates protease inhibition and complement activation in the anti-inflammatory properties of HDLJ Clin Invest200711774675617332893
   PubMed Web of Science ®Google Scholar
• GordonSMDengJLuLJDavidsonWSProteomic characterization of human plasma high density lipoprotein fractionated by gel filtration chromatographyJ Proteome Res201095239524920718489
   PubMed Web of Science ®Google Scholar
• LiWHTanimuraMLuoCCDattaSChanLThe apolipoprotein multigene family: biosynthesis, structure, structure-function relationships, and evolutionJ Lipid Res1988292452713288703
   PubMed Web of Science ®Google Scholar
• BashtovyyDJonesMKAnantharamaiahGMSegrestJPSequence conservation of apolipoprotein A-I affords novel insights into HDL structure-functionJ Lipid Res20115243545021159667
   PubMed Web of Science ®Google Scholar
• van der VeldeAEReverse cholesterol transport: from classical view to new insightsWorld J Gastroenterol2010165908591521157966
   PubMed Web of Science ®Google Scholar
• FitzgeraldMLMujawarZTamehiroNABC transporters, atherosclerosis and inflammationAtherosclerosis201021136137020138281
   PubMed Web of Science ®Google Scholar
• Yvan-CharvetLWangNTallARRole of HDL, ABCA1, and ABCG1 transporters in cholesterol efflux and immune responsesArterioscler Thromb Vasc Biol20103013914319797709
   PubMed Web of Science ®Google Scholar
• HaydenMRCleeSMBrooks-WilsonAGenestJJrAttieAKasteleinJJCholesterol efflux regulatory protein, Tangier disease and familial high-density lipoprotein deficiencyCurr Opin Lipidol20001111712210787172
   PubMed Web of Science ®Google Scholar
• FeigJEShamirRFisherEAAtheroprotective effects of HDL: beyond reverse cholesterol transportCurr Drug Targets2008919620318336237
   PubMed Web of Science ®Google Scholar
• deGomaEMdeGomaRLRaderDJBeyond high-density lipoprotein cholesterol levels evaluating high-density lipoprotein function as influenced by novel therapeutic approachesJ Am Coll Cardiol2008512199221118534265
   PubMed Web of Science ®Google Scholar
• NavabMReddySTVan LentenBJFogelmanAMHDL and cardiovascular disease: atherogenic and atheroprotective mechanismsNat Rev Cardiol2011822223221304474
   PubMed Web of Science ®Google Scholar
• TölleMPawlakASchuchardtMHDL-associated lysosphingolipids inhibit NAD(P)H oxidase-dependent monocyte chemoattractant protein-1 productionArterioscler Thromb Vasc Biol2008281542154818483405
   PubMed Web of Science ®Google Scholar
• SuzukiMPritchardDKBeckerLHigh-density lipoprotein suppresses the type I interferon response, a family of potent antiviral immunoregulators, in macrophages challenged with lipopolysaccharideCirculation20101221919192720974999
   PubMed Web of Science ®Google Scholar
• BursillCACastroMLBeattieDTHigh-density lipoproteins suppress chemokines and chemokine receptors in vitro and in vivoArterioscler Thromb Vasc Biol2010301773177820702809
   PubMed Web of Science ®Google Scholar
• MineoCYuhannaISQuonMJShaulPWHigh density lipoprotein-induced endothelial nitric-oxide synthase activation is mediated by Akt and MAP kinasesJ Biol Chem20032789142914912511559
   PubMed Web of Science ®Google Scholar
• FryirsMABarterPJAppavooMEffects of high-density lipoproteins on pancreatic beta-cell insulin secretionArterioscler Thromb Vasc Biol2010301642162820466975
   PubMed Web of Science ®Google Scholar
• LevineDMParkerTSDonnellyTMWalshARubinALIn vivo protection against endotoxin by plasma high density lipoproteinProc Natl Acad Sci U S A19939012040120448265667
   PubMed Web of Science ®Google Scholar
• Yvan-CharvetLWelchCPalgerTAIncreased inflammatory gene expression in ABC-transporter-deficient macrophages. Free cholesterol accumulation, increased signaling via Toll-like receptors, and neutrophils infiltration of atherosclerotic lesionsCirculation20081181837184718852364
   PubMed Web of Science ®Google Scholar
• SmythiesLEWhiteCRMaheshwariAApolipoprotein A-I mimetic 4F alters the function of human monocyte-derived macrophagesAm J Physiol Cell Physiol2010298C1538154820219948
   PubMed Web of Science ®Google Scholar
• TangCVaughanAMAnantharamaiahGMOramJFJanus kinase 2 modulates the lipid-removing but not protein stabilizing interactions of amphipathic helices with ABCA1J Lipid Res20064710711416210729
   PubMed Web of Science ®Google Scholar
• TangCLiuYKesslerPSVaughanAMOramJFThe macrophage cholesterol exporter ABCA1 functions as an anti-inflammatory receptorJ Biol Chem2009284323363234319783654
   PubMed Web of Science ®Google Scholar
• NavabMImesSSHamaSYMonocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoproteinJ Clin Invest199188203920461752961
   PubMed Web of Science ®Google Scholar
• AnsellBJNavabMHamaSInflammatory/anti-inflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatmentCirculation20031082751275614638544
   PubMed Web of Science ®Google Scholar
• PodrezEAAnti-oxidant properties of high-density lipoprotein and atherosclerosisClin Exp Pharmacol Physiol20103771972520374263
   PubMed Web of Science ®Google Scholar
• NavabMHamaSYAnantharamaiahGMNormal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: steps 2 and 3J Lipid Res2000411495150810974057
   PubMed Web of Science ®Google Scholar
• DegomaEMRaderDJNovel HDL-directed pharmacotherapeutic strategiesNat Rev Cardiol2011826627721243009
   PubMed Web of Science ®Google Scholar
• AnantharamaiahGMJonesJLBrouilletteCGStudies of synthetic peptide analogs of the amphipathic helix. Structure of complexes with dimyristoyl phosphatidycholineJ Biol Chem198526010248102554019510
   PubMed Web of Science ®Google Scholar
• YanceyPGBielickiJKJohnsonWJEfflux of cellular cholesterol and phospholipid to lipid-free apolipoproteins and class A amphipathic peptidesBiochemistry199534795579657794908
   PubMed Web of Science ®Google Scholar
• DattaGChaddhaMHamaSEffects of increasing hydrophobicity on the physical-chemical and biological properties of a class A amphipathic helical peptideJ Lipid Res2001421096110411441137
   PubMed Web of Science ®Google Scholar
• MishraVKPalgunachariMNLund-KatzSEffect of the arrangement of tandem repeating units of class A amphipathic a-helixes on lipid interactionsJ Biol Chem1995270160216117829491
   PubMed Web of Science ®Google Scholar
• WoolGDReardonCAGetzGSApolipoprotein A-I mimetic peptide helix number and helix linker influence potentially anti-atherogenic propertiesJ Lipid Res2008491268128318323574
   PubMed Web of Science ®Google Scholar
• DattaGEpandRFEpandRMAromatic residue position on the nonpolar face of class A amphipathic helical peptides determines biological activityJ Biol Chem2004279265092651715075321
   PubMed Web of Science ®Google Scholar
• AnantharamaiahGMMishraVKGarberDWStructural requirements for antioxidative and anti-inflammatory properties of apolipoprotein A-I mimetic peptidesJ Lipid Res2007481915192317570869
   PubMed Web of Science ®Google Scholar
• Van LentenBJWagnerACJungCLAnti-inflammatory apoA-I-mimetic peptides bind oxidized lipids with much higher affinity than human apoA-IJ Lipid Res2008492302231118621920
   PubMed Web of Science ®Google Scholar
• ImaizumiSGrijalvaVNavabML-4F differentially alters plasma levels of oxidized fatty acids resulting in more anti-inflammatory HDL in miceDrug Metab Lett2010413914820642447
   PubMedGoogle Scholar
• NavabMAnantharamaiahGMReddySTApolipoprotein A-I mimetic peptidesArterioscler Thromb Vasc Biol2005251325133115831812
   PubMed Web of Science ®Google Scholar
• NavabMAnantharamaihGMReddySTOral D-4F causes formation of pre-β high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages and in apolipoprotein E-null miceCirculation20041093215322015197147
   PubMed Web of Science ®Google Scholar
• OuJOuZJonesDWL-4F, an apolipoprotein A-1 mimetic, dramatically improves vasodilation in hypercholesterolemia and sickle cell diseaseCirculation20031072337234112732610
   PubMed Web of Science ®Google Scholar
• OuJWangJXuHEffects of D-4F on vasodilation and vessel wall thickness in hypercholesterolemic LDL receptor-null and LDL receptor/apolipoprotein A-I double-knockout mice on Western dietCirc Res2005971190119716224061
   PubMed Web of Science ®Google Scholar
• WoolGDCabanaVGLukensJ4F Peptide reduces nascent atherosclerosis and induces natural antibody production in apolipoprotein E-null miceFASEB J20112529030020876212
   PubMed Web of Science ®Google Scholar
• CaligiuriGKhallou-LaschetJVandaeleMPhosphorylcholine-targeting immunization reduces atherosclerosisJ Am Coll Cardiol20075054054617678738
   PubMed Web of Science ®Google Scholar
• BinderCJHörkköSDewanAPneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDLNat Med2003973674312740573
   PubMed Web of Science ®Google Scholar
• TabetFRemaleyATSegalinyAIThe 5A apolipoprotein A-I mimetic peptides displays antiinflammatory and antioxidant properties in vivo and in vitroArterioscler Thromb Vasc Biol20103024625219965776
   PubMed Web of Science ®Google Scholar
• GetzGSWoolGDReardonCAHDL apolipoprotein-related peptides in the treatment of atherosclerosis and other inflammatory disordersCurr Pharm Des2010163173318420687877
   PubMed Web of Science ®Google Scholar
• NavabMAnantharamaiahGMHamaSOral administration of an apoA-I mimetic peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterolCirculation200210529029211804981
   PubMed Web of Science ®Google Scholar
• NavabMAnantharamaiahGMHamaSD-4F and statins synergize to render HDL antiinflammatory in mice and monkeys and cause lesion regression in old apolipoprotein E-null miceArterioscler Thromb Vasc Biol2005251426143215845909
   PubMed Web of Science ®Google Scholar
• NavabMReddySTAnantharamaiahGMThe intestine maybe a major site of action for the ApoA-I mimetic peptide 4F whether the peptide is administered subcutaneously or orallyJ Lipid Res2011521200121021444758
   PubMed Web of Science ®Google Scholar
• Van LentenBJNavabMAnantharamaiahGMBugaGMReddySTFogelmanAMMultiple indications for anti-inflammatory apolipoprotein mimetic peptidesCurr Opin Investig Drugs2008911571162
   Google Scholar
• ShermanCBPetersonSJFrishmanWHApolipoprotein A-I mimetic peptides. A potential new therapy for the prevention of atherosclerosisCardiol Rev20101814114720395699
   PubMed Web of Science ®Google Scholar
• ZhangZDattaGZhangYApolipoprotein A-I mimetic peptide treatment inhibits inflammatory responses and improves survival in septic ratsAm J Physiol Heart Circ Physiol2009297H86687319561306
   PubMed Web of Science ®Google Scholar
• Charles-SchoemanCBanquerigoMLHamaSTreatment with an apolipoprotein A-1 mimetic peptide in combination with pravastatin inhibits collagen-induced arthritisClin Immunol200812723424418337176
   PubMed Web of Science ®Google Scholar
• WooJMLinZNavabMTreatment with apolipoprotein A-1 mimetic peptide reduces lupus-like manifestations in a murine lupus model of accelerated atherosclerosisArthritis Res Ther201012R9320482780
   PubMed Web of Science ®Google Scholar
• BloedonLTDunbarRDuffyDSafety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patientsJ Lipid Res2008491344135218323573
   PubMed Web of Science ®Google Scholar
• WatsonCEWeissbachNKjemsLTreatment of patients with cardiovascular disease with L-4F, an apo-A1 mimetic, did not improve select biomarkers of HDL functionJ Lipid Res20115236137321068008
   PubMed Web of Science ®Google Scholar